Next Article in Journal
To Trim or Not to Trim: Effects of Read Trimming on the De Novo Genome Assembly of a Widespread East Asian Passerine, the Rufous-Capped Babbler (Cyanoderma ruficeps Blyth)
Previous Article in Journal
Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort
Previous Article in Special Issue
Thyroid Cancer in the Pediatric Population
Open AccessReview

The Role of Molecular Testing for the Indeterminate Thyroid FNA

1
Division of Anatomic Pathology and Histology, Catholic University of Sacred Heart, 00168 Rome, Italy
2
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15232, USA
3
Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
*
Author to whom correspondence should be addressed.
Genes 2019, 10(10), 736; https://doi.org/10.3390/genes10100736
Received: 1 August 2019 / Revised: 13 September 2019 / Accepted: 18 September 2019 / Published: 23 September 2019
(This article belongs to the Special Issue Thyroid Cancer: Genetics and Targeted Therapies)
Thyroid nodules are common in the adult population where a majority are benign and only 4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early stages to evaluate and triage patients with thyroid nodules. While a definitive cytological diagnosis is provided in more than 70–75% of all thyroid FNA cases, the group of indeterminate lesions offers a challenge in terms of interpretation and clinical management. Molecular testing platforms have been developed, are recognized as an option by the 2015 American Thyroid Association Guidelines, and are frequently used in conjunction with FNA as an integral part of the cytologic evaluation. In this review, the utility of molecular testing options for nodules assigned to the group of indeterminate thyroid FNAs is described. View Full-Text
Keywords: fine needle aspiration; cytology; thyroid cancers; molecular testing; personalized medicine fine needle aspiration; cytology; thyroid cancers; molecular testing; personalized medicine
Show Figures

Figure 1

MDPI and ACS Style

Rossi, E.D.; Pantanowitz, L.; Faquin, W.C. The Role of Molecular Testing for the Indeterminate Thyroid FNA. Genes 2019, 10, 736.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop